Literature DB >> 23113506

Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection.

Diego C Borges1, Natalia M Araújo, Cristina R Cardoso, Javier E Lazo Chica.   

Abstract

During infection, the host response develops effector mechanisms to combat the parasite. However, this response can become uncontrolled or regulated by mechanisms that modulate the inflammatory reaction. The number of parasites that infects the host, such as trypomastigotes in Chagas disease, may also influence immune activation and disease pathology. We evaluated the inflammation and immune regulation that follows Trypanosoma cruzi infection with low (300), intermediate (3000) or high (30000) parasite loads. Our results showed that the load of parasite inoculum influenced disease outcome: the higher the number of parasites in the inoculum, the lower were the survival rates. There was a strong association between parasitism and inflammatory infiltrate in the heart and the parasite inoculum determined cytokine interplay in this tissue, as shown by increased interferon-γ, tumour necrosis factor-α, interleukin-17 (IL-17) and IL-23 in the 300 and 30000 inoculum groups, higher IL-4 and IL-10 in the intermediate-inoculum mice, and elevated IL-6 production in the heart of mice in the 3000 and 30000 groups. The number of T cells and antigen-presenting cells was augmented in the infected groups, especially for the splenic CD4(+) CD25(+) regulatory T cells expressing CD45RB(low) , GITR, PD-1 and FoxP3 in the group with the highest inoculum. Interestingly, these mice also presented an apparent decrease in CD4(+) CD25(+) FoxP3(+) cells in the cardiac infiltrate, in contrast to the intermediate inoculum group, which showed elevated numbers of these regulatory leucocytes in the heart. Finally, our results demonstrated that parasite load during T. cruzi infection is linked to the response pattern that will result in parasite/inflammation control or tissue damage.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23113506      PMCID: PMC3575767          DOI: 10.1111/imm.12022

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  60 in total

1.  Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.

Authors:  V Michailowsky; N M Silva; C D Rocha; L Q Vieira; J Lannes-Vieira; R T Gazzinelli
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi.

Authors:  Z BRENER
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1962 Nov-Dec       Impact factor: 1.846

Review 3.  Innate and acquired immunity in the pathogenesis of Chagas disease.

Authors:  Denise Golgher; Ricardo T Gazzinelli
Journal:  Autoimmunity       Date:  2004-08       Impact factor: 2.815

4.  Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells.

Authors:  Angel Padilla; Dan Xu; Diana Martin; Rick Tarleton
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

5.  Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.

Authors:  Joshua Kotner; Rick Tarleton
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

6.  Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.

Authors:  D F Hoft; A R Schnapp; C S Eickhoff; S T Roodman
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

7.  IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis.

Authors:  Paulo Marcos da Matta Guedes; Fredy R S Gutierrez; Flavia L Maia; Cristiane M Milanezi; Grace K Silva; Wander R Pavanelli; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2010-02-16

8.  The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies.

Authors:  M L Higuchi; C F De Morais; A C Pereira Barreto; E A Lopes; N Stolf; G Bellotti; F Pileggi
Journal:  Clin Cardiol       Date:  1987-11       Impact factor: 2.882

9.  Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells.

Authors:  Fumiko Kanamaru; Pornpan Youngnak; Masaaki Hashiguchi; Tomohisa Nishioka; Takeshi Takahashi; Shimon Sakaguchi; Isao Ishikawa; Miyuki Azuma
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

10.  Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells.

Authors:  Megan K Levings; Silvia Gregori; Eleonora Tresoldi; Sabrina Cazzaniga; Chiara Bonini; Maria Grazia Roncarolo
Journal:  Blood       Date:  2004-10-12       Impact factor: 22.113

View more
  19 in total

Review 1.  Diagnosis and Management of Chagas Cardiomyopathy in the United States.

Authors:  Lillian Benck; Evan Kransdorf; Jignesh Patel
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

Review 2.  CD8+ T cells in Trypanosoma cruzi infection.

Authors:  Rick L Tarleton
Journal:  Semin Immunopathol       Date:  2015-04-29       Impact factor: 9.623

Review 3.  Chronic Chagas Disease-the Potential Role of Reinfections in Cardiomyopathy Pathogenesis.

Authors:  Christian Olivo Freites; Hendrik Sy; Amal Gharamti; Nelson I Agudelo Higuita; Carlos Franco-Paredes; José Antonio Suárez; Andrés F Henao-Martínez
Journal:  Curr Heart Fail Rep       Date:  2022-08-11

4.  Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy.

Authors:  Denise Mayumi Tanaka; Luciano Fonseca Lemos de Oliveira; José Antônio Marin-Neto; Minna Moreira Dias Romano; Eduardo Elias Vieira de Carvalho; Antonio Carlos Leite de Barros Filho; Fernando Fonseca França Ribeiro; Jorge Mejia Cabeza; Carla Duque Lopes; Camila Godoy Fabricio; Norival Kesper; Henrique Turin Moreira; Lauro Wichert-Ana; André Schmidt; Maria de Lourdes Higuchi; Edécio Cunha-Neto; Marcus Vinícius Simões
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

5.  Mass Spectrometry-Based Chemical Cartography of a Cardiac Parasitic Infection.

Authors:  Laura-Isobel McCall; James T Morton; Jean A Bernatchez; Jair Lage de Siqueira-Neto; Rob Knight; Pieter C Dorrestein; James H McKerrow
Journal:  Anal Chem       Date:  2017-09-22       Impact factor: 6.986

6.  Role of cyclooxygenase-2 in Trypanosoma cruzi survival in the early stages of parasite host-cell interaction.

Authors:  Karen C M Moraes; Lívia F Diniz; Maria Terezinha Bahia
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-04       Impact factor: 2.743

7.  Metabolomic profiling in cattle experimentally infected with Mycobacterium avium subsp. paratuberculosis.

Authors:  Jeroen De Buck; Rustem Shaykhutdinov; Herman W Barkema; Hans J Vogel
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

8.  Inflammatory responses and intestinal injury development during acute Trypanosoma cruzi infection are associated with the parasite load.

Authors:  Bruna Perez Vazquez; Thaís Perez Vazquez; Camila Botelho Miguel; Wellington Francisco Rodrigues; Maria Tays Mendes; Carlo José Freire de Oliveira; Javier Emílio Lazo Chica
Journal:  Parasit Vectors       Date:  2015-04-03       Impact factor: 3.876

9.  IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes.

Authors:  Eugenia Hovsepian; Federico Penas; Sofía Siffo; Gerardo A Mirkin; Nora B Goren
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

10.  In vitro and in vivo trypanocidal activity of H2bdtc-loaded solid lipid nanoparticles.

Authors:  Zumira A Carneiro; Pedro I da S Maia; Renata Sesti-Costa; Carla D Lopes; Tatiana A Pereira; Cristiane M Milanezi; Marcelo A Pereira da Silva; Renata F V Lopez; João S Silva; Victor M Deflon
Journal:  PLoS Negl Trop Dis       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.